EICHOR
● Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer Recurrent · Sponsor: Coherus Oncology, Inc.
About this study
This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.
This description comes directly from the study's public registry record.
Talk to the study team
Clinical Operations Team Clinical Operations · 800-794-5434 · clinicaltrials@coherus.com
Always discuss trial participation with your own doctor first.
Locations (13)
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| University of California, Irvine | Irvine, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Emory Winship Cancer Institute | Atlanta, Georgia, United States | Recruiting |
| Boston Medical Center | Boston, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Henry Ford Cancer Center | Detroit, Michigan, United States | Recruiting |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | New York, New York, United States | Withdrawn |
| University of Cincinnati Medical Center | Cincinnati, Ohio, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| Penn State Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
| Froedtert Hospital and the Medical College of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06457503